Goldman Sachs Group Inc Fennec Pharmaceuticals Inc. Transaction History

Goldman Sachs Group Inc

$555 Billion
Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 43,091 shares of FENC stock, worth $263,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,091

Previous 31,000 39.0%

Holding current value

$263,286

Previous $347,000 38.04%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.82 - $11.12 $106,642 - $134,451	12,091 Added 39.0%	43,091 $479,000
Q4 2023 Feb 13, 2024	BUY	$6.48 - $11.61 $88,542 - $158,639	13,664 Added 78.82%	31,000 $347,000
Q3 2023 May 14, 2024	SELL	$7.15 - $8.94 $97,697 - $122,156	-13,664 Reduced 44.08%	17,336 $130,000
Q3 2023 Nov 14, 2023	SELL	$7.15 - $8.94 $96,496 - $120,654	-13,496 Reduced 43.77%	17,336 $130,000
Q2 2023 May 14, 2024	BUY	$7.27 - $9.82 $73,288 - $98,995	10,081 Added 48.58%	30,832 $272,000

Q2 2023 Aug 14, 2023	BUY	$7.27 - $9.82 $73,288 - $98,995	10,081 Added 48.58%	30,832 $272,000
Q1 2023 May 14, 2024	SELL	$7.38 - $10.35 $1,726 - $2,421	-234 Reduced 1.12%	20,751 $172,000
Q1 2023 May 11, 2023	SELL	$7.38 - $10.35 $1,726 - $2,421	-234 Reduced 1.12%	20,751 $172,000
Q4 2022 May 14, 2024	BUY	$7.91 - $10.22 $86,661 - $111,970	10,956 Added 109.24%	20,985 $201,000
Q4 2022 Feb 13, 2023	BUY	$7.91 - $10.22 $165,991 - $214,466	20,985 New	20,985 $201,000
Q2 2022 May 14, 2024	SELL	$5.17 - $6.33 $108,420 - $132,746	-20,971 Reduced 67.65%	10,029 $56,000
Q2 2022 Aug 15, 2022	SELL	$5.17 - $6.33 $15,773 - $19,312	-3,051 Reduced 23.33%	10,029 $56,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.08 $1,578 - $2,237	-368 Reduced 2.74%	13,080 $73,000
Q4 2021 Feb 14, 2022	BUY	$3.89 - $10.01 $62 - $160	16 Added 0.12%	13,448 $59,000
Q3 2021 Nov 10, 2021	BUY	$6.51 - $9.62 $87,442 - $129,215	13,432 New	13,432 $127,000

Others Institutions Holding FENC

# of Institutions

Shares Held

14.4M

Call Options Held

53.2K

Put Options Held

83.9K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $159M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Fennec Pharmaceuticals Inc. Transaction History